| Follow us on |  |
 |
 |
Gastric Balloon Procedure
Gastric Balloon Facts
Most patients will have tried many different diets and lifestyle changes without success. Patients will be educated as to what will happen during the procedure to insert the Gastric Balloon, and during the days, weeks and months after it is in place. They need to understand that their diet will be restricted for some days after the procedure and that they will likely have some nausea and/or vomiting in the first week.
Most importantly, we will discuss realistic expectations about the amount of weight they will lose, and they must understand that the success of the procedure depends on their effort as well as the device.
A multidisciplinary team is available to develop a program for each patient. In addition to regular follow up with our dietitian, patients have access to our wellness coach. As well we will recommend the develop an exercise regime to complement the Gastric Balloon while it is in place. Optimal weight loss while the Gastric Balloon is in place and maintenance of the weight loss achieved requires a permanent change to their eating and exercise behaviour.
In addition to verbal information given to them during their consultation, patients will be offered booklets and links to useful websites which provide further advice and support.
How much weight will the patient lose?
Patients are advised that the amount of weight they lose will depend on how well they adapt to the Gastric Balloon and their ability and desire to alter their eating behaviour. A reasonable goal is to average a loss of 1kg per week, throughout the six months that they have the Gastric Balloon, giving a total weight loss of about 15-25kg. Experience has shown that 70-80% of a patient's weight loss typically occurs during the first three months of treatment. After that time, the presence of the balloon plays a more supportive role in helping patients to maintain their dietary/exercise routine.
Procedure DetailsGastric Balloon References:
1. Adams KF, et al., Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. New England Journal of Medicine 2006; 355: 763-7782. Fried M, et al., Inter-disciplinary European guidelines on surgery of severe obesity. International Journal of Obesity 2007; 31: 569-577
3. Buchwald H. Consensus Conference Statement. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surgery for Obesity and Related Diseases 2005; 1: 371-381
4. Lau DCW for the Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. Canadian Medical Association Journal 2007; 176; 1103-1106
5. National Institute for Health and Clinical Excellence. Clinical guideline 43. Obesity guidance on the prevention, assessment and management of overweight and obesity in adults and children, December 2006
6. Genco A, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obesity Surgery 2005; 15: 1161-1164
7. Sallet JA, et al. Brazilian multicenter study of the intragastric balloon. Obesity Surgery 2004; 14:991-998
8. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19-27
9. Cobourn C. et al., Expert Approaches to Weight Loss Management, Issue 1, The Allergan ORBERA™ Managed Weight Loss System